Bangkok Lab & Cosmetic PCL

BLC, or Bangkok Lab and Cosmetic Public Company Limited, revealed during its Opportunity Day that it targets second-half sales of 900 million to 1 billion baht, while proceeding with its JUMP+ plan for long-term growth. In the second quarter of 2026, the company posted a net profit of 29.87 million baht and revenue from sales and services of 399 million baht. Despite the economic slowdown, demand for medicines and health products continues to support the business. The company will accelerate the launch of three new generic drugs in 2027 to compensate for delays in 2026 and expand the herbal medicine market. Capsika-75 has been included in the National List of Essential Medicines, while Vina is being developed as a spray form, and Kachana from black ginger is expected to launch in 2027. The new factory is 99% complete and is expected to begin full operations in early 2027 to increase production capacity, especially for creams. Under the JUMP+ plan, the company targets average annual revenue growth of 15-20%, profit growth of 20-25% per year, and EBITDA of 563 million baht. It is also advancing ESG initiatives through certification for CAC and ISO 27001, as well as installing solar rooftops.

Bangkok Lab and Cosmetic Public Company Limited, or BLC, reported its first-half 2026 performance with revenue of 816.8 million baht and net profit of 60.6 million baht. Management expects continued growth in the second half, driven by high-potential product groups, customer base expansion, and increased production capacity from a new factory that is 99% complete. This will support OEM/CDMO contract manufacturing with both domestic and international partners, representing a new S-Curve for the company. Additionally, the board approved an interim dividend of 0.05 baht per share, with the XD date on August 21, 2026, the record date on August 24, and cash payment on September 9, 2026.

Bangkok Lab and Cosmetic, or BLC, plans to launch three new products in the second half of 2026, comprising two herbal products and one new generic drug. The company is also preparing to begin system testing at its newly completed factory to unlock production capacity constraints and support future growth. Chief Executive Officer Suvit Ngamphuphan said the new plant will enter the system testing phase to fully drive the company into a new S-curve. For the second quarter of 2026, the company posted total sales and service revenue of 399.0 million baht, down 4.5 percent from the previous quarter and down 3.3 percent from the same period last year. However, the herbal product segment continued to stand out, generating revenue of 46.5 million baht, an increase of 8.0 million baht from the previous quarter and 16.10 million baht from the prior year, with the Plaivana brand in particular achieving 18 percent sales growth year-on-year. Net profit for the second quarter was 30.2 million baht, with net profit margin rising to 7.6 percent from 7.3 percent in the first quarter. Additionally, the board of directors meeting on August 10, 2026 approved an interim dividend payment of 0.05 baht per share, totaling 30 million baht, with the XD date set for August 21, 2026 and payment on September 9, 2026.

Bangkok Lab and Cosmetic, or BLC, is expanding its sports marketing base by deploying the Plai Vana brand as a main sponsor of the national Muay Thai tournament King of Fight, under the slogan Thai Heritage For Every Fighter, to link the martial art of Muay Thai with plai, a Thai herb long used to treat aches and pains. Chief Executive Officer Suwit Ngamphuphan revealed that sports injury rates among teenagers and early working-age adults have risen by around 20 to 30 percent, driven by the heavy exercise trends of the new generation, leading the company to see growth opportunities in the pain relief product segment. Plai Vana contains 14 percent plai oil, helping to relieve sprains and muscle aches in a portable, easy-to-use cream format. The company expects that supporting King of Fight will help drive standout growth for its pain relief product line and reinforce BLC's image in expanding its consumer base among athletes and the new generation with active lifestyles.